Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Detection of EGFR gene mutations in non-small cell lung cancer: lessons from a single-institution routine analysis of 1,403 tumor samples.

Vallee A, Sagan C, Le Loupp AG, Bach K, Dejoie T, Denis MG.

Int J Oncol. 2013 Oct;43(4):1045-51. doi: 10.3892/ijo.2013.2056. Epub 2013 Aug 7.

PMID:
23934203
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].

Sun MH, Yang F, Shen L, Zhang L, Chen Y, Cai X, Zhu XL, Zhou XY.

Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):655-9. Chinese.

PMID:
22321541
[PubMed - indexed for MEDLINE]
3.

[Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer].

Wang S, Han XH, Li JL, Hu XS, Wang XY, Gui L, Zhao LD, Sun Y, Shi YK.

Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):530-3. doi: 10.3760/cma.j.issn.0529-5807.2012.08.005. Chinese.

PMID:
23157744
[PubMed - indexed for MEDLINE]
4.

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

Bai H, Mao L, Wang HS, Zhao J, Yang L, An TT, Wang X, Duan CJ, Wu NM, Guo ZQ, Liu YX, Liu HN, Wang YY, Wang J.

J Clin Oncol. 2009 Jun 1;27(16):2653-9. doi: 10.1200/JCO.2008.17.3930. Epub 2009 May 4.

PMID:
19414683
[PubMed - indexed for MEDLINE]
Free Article
5.

Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.

Kim HJ, Lee KY, Kim YC, Kim KS, Lee SY, Jang TW, Lee MK, Shin KC, Lee GH, Lee JC, Lee JE, Kim SY.

Lung Cancer. 2012 Mar;75(3):321-5. doi: 10.1016/j.lungcan.2011.08.005. Epub 2011 Sep 17.

PMID:
21930325
[PubMed - indexed for MEDLINE]
6.

Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer.

Horiike A, Kimura H, Nishio K, Ohyanagi F, Satoh Y, Okumura S, Ishikawa Y, Nakagawa K, Horai T, Nishio M.

Chest. 2007 Jun;131(6):1628-34.

PMID:
17565015
[PubMed - indexed for MEDLINE]
7.

Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration.

Nakajima T, Yasufuku K, Suzuki M, Hiroshima K, Kubo R, Mohammed S, Miyagi Y, Matsukuma S, Sekine Y, Fujisawa T.

Chest. 2007 Aug;132(2):597-602. Epub 2007 Jun 15.

PMID:
17573511
[PubMed - indexed for MEDLINE]
8.

High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.

Sun PL, Seol H, Lee HJ, Yoo SB, Kim H, Xu X, Jheon S, Lee CT, Lee JS, Chung JH.

J Thorac Oncol. 2012 Feb;7(2):323-30. doi: 10.1097/JTO.0b013e3182381515.

PMID:
22237264
[PubMed - indexed for MEDLINE]
9.

[EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics].

Tapia C, Savic S, Bihl M, Rufle A, Zlobec I, Terracciano L, Bubendorf L.

Pathologe. 2009 Sep;30(5):384-92. doi: 10.1007/s00292-009-1141-4. German.

PMID:
19357847
[PubMed - indexed for MEDLINE]
10.

Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1).

Beau-Faller M, Degeorges A, Rolland E, Mounawar M, Antoine M, Poulot V, Mauguen A, Barbu V, Coulet F, Prétet JL, Bièche I, Blons H, Boyer JC, Buisine MP, de Fraipont F, Lizard S, Olschwang S, Saulnier P, Prunier-Mirebeau D, Richard N, Danel C, Brambilla E, Chouaid C, Zalcman G, Hainaut P, Michiels S, Cadranel J.

J Thorac Oncol. 2011 Jun;6(6):1006-15. doi: 10.1097/JTO.0b013e318211dcee.

PMID:
21532509
[PubMed - indexed for MEDLINE]
11.

A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells.

Molina-Vila MA, Bertran-Alamillo J, Reguart N, Taron M, Castellà E, Llatjós M, Costa C, Mayo C, Pradas A, Queralt C, Botia M, Pérez-Cano M, Carrasco E, Tomàs M, Mate JL, Moran T, Rosell R.

J Thorac Oncol. 2008 Nov;3(11):1224-35. doi: 10.1097/JTO.0b013e318189f579.

PMID:
18978556
[PubMed - indexed for MEDLINE]
12.

EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report.

Kamila WK, Michał S, Paweł K, Paulina J, Tomasz K, Bożena J, Radosław M, Justyna S, Marek S, Trojanowski T, Janusz M, Joanna CW.

Clin Exp Metastasis. 2013 Dec;30(8):1063-71. doi: 10.1007/s10585-013-9603-8. Epub 2013 Jul 27.

PMID:
23892415
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].

Zhou CC, Zhou SW, Pan H, Su B, Gao ZQ.

Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):119-23. Chinese.

PMID:
17645848
[PubMed - indexed for MEDLINE]
14.

EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients.

Malapelle U, Bellevicine C, De Luca C, Salatiello M, De Stefano A, Rocco D, de Rosa N, Vitiello F, Russo S, Pepe F, Iaccarino A, Micheli P, Illiano A, Carlomagno C, Piantedosi FV, Troncone G.

Cancer Cytopathol. 2013 Oct;121(10):552-60. doi: 10.1002/cncy.21322. Epub 2013 Jun 18.

PMID:
23780873
[PubMed - indexed for MEDLINE]
15.

[Relationship between mutations of epidermal growth factor receptor gene and clinicopathologic features of non-small cell lung cancers].

Wang F, Fu S, Tang T, Deng L, Zhang X, Li YZ, Shao JY.

Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):664-6. Chinese.

PMID:
22321543
[PubMed - indexed for MEDLINE]
16.

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.

Tomizawa Y, Iijima H, Sunaga N, Sato K, Takise A, Otani Y, Tanaka S, Suga T, Saito R, Ishizuka T, Dobashi K, Minna JD, Nakajima T, Mori M.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6816-22.

PMID:
16203769
[PubMed - indexed for MEDLINE]
Free Article
17.

Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients.

Zhao X, Han RB, Zhao J, Wang J, Yang F, Zhong W, Zhang L, Li LY, Wang MZ.

Respiration. 2013;85(2):119-25. doi: 10.1159/000338790. Epub 2012 Jul 10.

PMID:
22797485
[PubMed - indexed for MEDLINE]
18.

L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.

Sasaki H, Endo K, Takada M, Kawahara M, Kitahara N, Tanaka H, Okumura M, Matsumura A, Iuchi K, Kawaguchi T, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2006 Oct;54(1):103-8. Epub 2006 Aug 4.

PMID:
16890322
[PubMed - indexed for MEDLINE]
19.

Detection of epidermal growth factor receptor mutations in a few cancer cells from transbronchial cytologic specimens by reverse transcriptase-polymerase chain reaction.

Kanaji N, Bandoh S, Ishii T, Kushida Y, Haba R, Kohno K, Dobashi H, Ohnishi H, Matsunaga T.

Mol Diagn Ther. 2011 Dec 1;15(6):353-9. doi: 10.2165/11595700-000000000-00000.

PMID:
22117119
[PubMed - indexed for MEDLINE]
20.

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.

Lozano MD, Zulueta JJ, Echeveste JI, Gúrpide A, Seijo LM, Martín-Algarra S, Del Barrio A, Pio R, Idoate MA, Labiano T, Perez-Gracia JL.

Oncologist. 2011;16(6):877-85. doi: 10.1634/theoncologist.2010-0155. Epub 2011 May 14.

PMID:
21572125
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk